Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

Clinical trial NCT00093613 · COMPLETED

Trial details

NCT number: NCT00093613
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Anaplastic Astrocytoma Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor

Start date: 2004-12-01
Primary completion: 2010-10-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.